Trending...
- New Rochelle: Department of Parks & Recreation Announces Summer Programming in Neighborhood Parks
- New Rochelle: Joint Campaign Launched for Earth Month
- BET Remembers Hip-Hop Icon DMX With Special Linear Programming Today Starting At 6PM/5C
NEW YORK--(BUSINESS WIRE)--IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Glenn P. Sblendorio, Chief Executive Officer and President, and Pravin U. Dugel, M.D., Chief Strategy and Business Officer, will participate in a fireside chat at the Cowen 41st Annual Health Care Conference virtually on Thursday, March 4 at 9:50 a.m. Eastern Time.
Investors and the general public are invited to listen to a live webcast of the presentation on the Investor / Events & Presentations section of the Iveric Bio website at www.ivericbio.com. An archived replay of the webcast will be available on the Company's website immediately following the conference and for at least two weeks thereafter.
About Iveric Bio
Iveric Bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases. Vision is Our Mission. For more information on the Company, please visit www.ivericbio.com.
More on Nyenta.com
Forward-looking Statements
Any statements in this press release about Iveric Bio's future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors. Any forward-looking statements represent Iveric Bio's views only as of the date of this press release. Iveric Bio anticipates that subsequent events and developments will cause its views to change. While Iveric Bio may elect to update these forward-looking statements at some point in the future, Iveric Bio specifically disclaims any obligation to do so.
ISEE-G
Investors and the general public are invited to listen to a live webcast of the presentation on the Investor / Events & Presentations section of the Iveric Bio website at www.ivericbio.com. An archived replay of the webcast will be available on the Company's website immediately following the conference and for at least two weeks thereafter.
About Iveric Bio
Iveric Bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases. Vision is Our Mission. For more information on the Company, please visit www.ivericbio.com.
More on Nyenta.com
- Paradigm Technology Group Joins The Evolve IP Partner Program
- Delirious Comedy Club Presents Pauly Shore Every Friday Night In April
- New Rochelle: FEMA Announces Financial Assistance for COVID-19 Funeral Expenses
- PADT Named EOS Metal 3D Printing Distribution Partner Across the Southwest, Expanding its Established Additive Manufacturing Products Offering
- Book Release - Joab, King David's Top General: Essential Lessons on Character"
Forward-looking Statements
Any statements in this press release about Iveric Bio's future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors. Any forward-looking statements represent Iveric Bio's views only as of the date of this press release. Iveric Bio anticipates that subsequent events and developments will cause its views to change. While Iveric Bio may elect to update these forward-looking statements at some point in the future, Iveric Bio specifically disclaims any obligation to do so.
ISEE-G
Filed Under: Business
0 Comments
Latest on Nyenta.com
- AdvisorSmith Finds the Average Price of Renters Insurance
- Deb Hoffmann, Guinness World Record Holder for Largest Winnie the Pooh Collection, Shatters 20,000-Item Ceiling
- Post-Merged Entity of Helbiz and GreenVision Acquisition Corp to Appoint Four New Members to its Board of Directors
- Histria Books announces the release of Molly – A Love Story to help support animal shelters
- Floating Solar Panels Market Analysis, Leading Players, Growth and Future Scope
- ATC Healthcare Services Launches Times Square Pop-Up Vaccine Clinic Staffed by Laid-Off Broadway Workers
- Author's Stunning Coming of Age Novel Wins Multiple Literary Awards
- Flashpoint's Unrivaled Innovation Extends Threat Intelligence Suite with Two New Products
- Handy Announces Partnership with Savvy
- JetQuay Launches Private Swab Test Facility, Halves Custom Clearance Timing
- Booka Announces New Partnership with Caramel Publishing House and Launches Read-to-Me Feature
- S&P Global Ratings Announces Regulatory Website Redesign and Integration
- Interparfums SA Completes the Acquisition of Its Future Headquarters in Paris
- New Rochelle: Never Miss Your Waste Collection Day Again!
- New Rochelle Earth Day Virtual Forum April 22
- New Rochelle Earth Day Virtual Forum April 22
- New Rochelle: Department of Parks & Recreation Announces Summer Programming in Neighborhood Parks
- New Rochelle: Never Miss Your Waste Collection Day Again!
- New Rochelle: Joint Campaign Launched for Earth Month
- New Rochelle: Joint Campaigns Launched for Earth Month